The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Gemayel Georges since 2018.
This trader's CIK number is 1256088.
At the time of last reporting, Gemayel Georges was the Officer of Supernus Pharmaceuticals, Inc.. (stock ticker symbol SUPN).
Also see all insider trading activities at Supernus Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | MNTA | 0 | $0 | 20,000 | $630,000 | 20,000 | $296,800 |
| 2019 | MNTA | 0 | $0 | 0 | $0 | 4,356 | $0 |
| 2018 | MNTA | 0 | $0 | 0 | $0 | 5,734 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2026 | SUPN | 0 | $0 | 0 | $0 | 15,000 | $194,700 |
| 2024 | SUPN | 0 | $0 | 24,673 | $826,616 | 20,787 | $238,219 |
1. Momenta Pharmaceuticals Inc (MNTA)
2. Supernus Pharmaceuticals, Inc. (SUPN)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-08-05 | MNTA | Option Ex | 10,000 | 14.84 | 148,400 |
| 2020-08-05 | MNTA | Sale | 10,000 | 33.00 | 330,000 |
| 2020-07-29 | MNTA | Option Ex | 10,000 | 14.84 | 148,400 |
| 2020-07-29 | MNTA | Sale | 10,000 | 30.00 | 300,000 |
| 2019-06-20 | MNTA | Option Ex | 4,356 | .00 | 0 |
| 2018-06-20 | MNTA | Option Ex | 5,734 | .00 | 0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-02-23 | SUPN | Option Ex | 15,000 | 12.98 | 194,700 |
| 2024-11-08 | SUPN | Option Ex | 10,787 | 11.46 | 123,619 |
| 2024-11-08 | SUPN | Sale | 10,787 | 36.30 | 391,568 |
| 2024-09-13 | SUPN | Sale | 13,886 | 31.33 | 435,048 |
| 2024-09-13 | SUPN | Option Ex | 10,000 | 11.46 | 114,600 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Gemayel Georges (Officer of Supernus Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.